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Introduction
Postoperative morbidity and mortality, especially in cancer
patients, have been reviewed in a number of studies in the
field of gynecology [1–3]. Morbidity after gynaecological
surgery ranges from approximately 10% to 20%, whereas
mortality is extremely rare [4–6]. Clinical guidelines and rec-
ommendations based on the unusual events of patient death
are of little importance in medical care of the general popula-
tion, and therefore information on severe acute morbidity as
evidenced by near-miss cases and utilisation of intensive care
units (ICUs) may help to audit the quality of care in a more
meaningful manner. Reports on the utilisation and outcomes
of critical care services required in the management of all
gynaecological patients are rare. The other side of the coin is
that severe morbidity and the need for intensive care poorly
reflect the long-term effects leading to mortality after dis-
charge from hospital. As far as we are aware, studies of the
need for intensive care in gynaecology have not been recently
conducted in the Nordic countries, where patient care is
organised by public health care units, and thus virtually all
women receive modern care. This study was undertaken to
APACHE II = Acute Physiological and Chronic Health Evaluation II; ICU = intensive care unit; IVF = in vitro fertilisation; TISS = Therapeutic
Intervention Scoring System.
Abstract
Introduction The purpose of this study was to note potential gynaecological risk factors leading to
intensive care and to estimate the frequency, costs and outcome of management.
Materials and methods In a cross-sectional study of intensive care admissions in Kuopio from March
1993 to December 2000, 23 consecutive gynaecological patients admitted to a mixed medical–
surgical intensive care unit (ICU) were followed. We recorded demographics, admitting diagnoses,
scores on the Acute Physiological and Chronic Health Evaluation (APACHE) II, clinical outcome and
treatment costs.
Results The overall need for intensive care was 2.3 per 1000 women undergoing major surgery during
the study period. Patients were 55.4 ± 16.9 (mean ± SD) years old, with a mean APACHE II score of
14.07 (± 5.57). The most common diagnoses at admission were postoperative haemorrhage (43%),
infection (39%) and cardiovascular disease (30%). The duration of stay in the ICU was 4.97 (± 9.28)
(range 1–42 ) days and the mortality within 6 months was 26%, although the mortality in the ICU was
0%. The total cost of intensive care was approximately US$7044 per patient.
Conclusions Very few gynaecological patients develop complications requiring intensive care. The
presence of gynaecological malignancy and pre-existing medical disorders are clinically useful predictors
of eventual outcome, but many cases occur in women with a low risk and this implies that the risk is
relevant to all procedures. Further research is needed to determine effective preventive approaches.
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evaluate the population-based frequency, causes, costs and
outcome of intensive care in gynaecology.
Materials and methods
We retrospectively reviewed all gynaecological patients
treated in the intensive care unit at Kuopio University Hospital
from March 1993 to December 2000. In this study, by
‘gynaecological patients’ we mean patients who were admit-
ted to the hospital primarily on gynaecological indications.
Our institution is a tertiary care facility dealing with all kinds of
gynaecological care from assisted reproduction (180 IVF
cycles per year) to outpatient (950 operations) and major
surgery (1020 patients each year), including a gynaecological
oncology service, and it is part of a general hospital complex
having a surgical/medical intensive care unit. About 10% of
the operations are transfers from a provincial referral base of
one million inhabitants, mainly because of invasive cancer or
pre-existing medical disorder considered to pose a high risk
to the woman. Our hospital has 24-hour on-site consultants in
gynaecology, anaesthesia and intensive care. Laboratory,
blood bank and haematology facilities are available in the unit.
Gynaecological patients with respiratory failure or unstable
haemodynamics are transferred to the ICU.
The Intensive Care Unit at Kuopio University Hospital is a 22-
bed tertiary care and medical/surgical intensive care unit.
Intensive care patients are treated by critical care staff physi-
cians. The anaesthetist or gynaecologist consults the inten-
sive care physician, who makes the decision as to whether or
not the patient is to be admitted to the ICU. Patients under-
going radical cancer surgery are routinely monitored during
emergence from anaesthesia in the postanesthesia care unit
for the first postoperative night, and, if stable the next
morning, are transferred to a ward for further postoperative
care. In this study, the time in the postanesthesia care unit
was not counted as utilisation of the critical care services,
and thus patients were admitted to the ICU on specific clini-
cal indication only. Subsequent care is primarily in the hands
of the ICU team in close cooperation with the Department of
Gynaecology. Our ICU provides all intensive care services for
patients aged over 1 year in a primary population of 256,000
inhabitants. All patients in this referral population requiring inten-
sive care are treated in our institution. For the most part, the
same staff took care of all the patients over the study period.
Gynaecological patients and women with pregnancy-related
complications who were treated in the ICU before 16 weeks
of pregnancy were enrolled in this study. Each case requiring
intensive care was documented with respect to the marker of
severe acute morbidity, the primary factor (the initiating event
leading to transferral) and any organ dysfunction or failure (list
of organ systems involved). Women who had multiple compli-
cations were included under more than one heading. The
main purpose of such classification was to assist in preven-
tion programmes. Hospital charts were reviewed to determine
the length of time in the ICU, specific interventions and
overall outcome of all patients. For each patient, the Acute
Physiology and Chronic Health Evaluation (APACHE) II score
was calculated at the time of admission [7]. Patients’ records
for the 6 months following the study were reviewed as
regards survival.
To conduct an economic analysis, the intensity of treatment
during the ICU stay was evaluated on a daily basis by using
the Therapeutic Intervention Scoring System (TISS) for each
patient [8]. The costs of intensive care were calculated by
dividing the yearly total cost of the department by the total
TISS score. Thus, the total cost covered all the salaries,
materials, full allocation of step-down costs (e.g. administra-
tion, depreciation, rent) and all secondary expenses such as
the use of laboratory and imaging facilities and consultations
with personnel of other specialities. Overall, the mean cost of
one TISS point was US$31, and based on this figure, the
total cost of the intensive care of the 23 gynaecological
patients was calculated.
Results
During the study period, there were 8573 gynaecological
operations in Kuopio University Hospital. There were 23
women who fitted the definition of a critically ill patient and
they were admitted to the ICU, the frequency of admissions
being 2.3 per 1000 women undergoing major surgery over
the years studied. For comparison, the equivalent figure for
urological patients undergoing pelvic surgery was 5.8 per
1000 during the same period of time. Of all gynaecological
patients requiring intensive care, two (9%) were received as
tertiary referrals from other hospitals. The utilisation rate of
the ICU varied from two to six admissions per year during the
study period. The mean (±  SD) number of days of intensive
care required was 4.97 (± 9.28). There was no mortality in
the operating theatre or in the ICU, but critically ill patients
beyond surgical treatment and with progressive terminal
disease were not admitted to the ICU. No specific trend in
the utilisation rate during the study period was recorded.
Intensive care of gynaecological patients accounted for
0.17% of all admissions to the ICU and for 0.31% of all care
days in the unit, and the equivalent parameter with regard to
TISS scores was 0.30% of all care days in the unit during the
study period.
The clinical characteristics of the women admitted to the ICU
are presented in Table 1. Gynaecological malignancies and
cardiovascular diseases leading to respiratory failure were the
most prevalent disease categories. In comparison with gynae-
cological patients who had benign diseases, the cancer
patients were specifically at high risk for ICU admission, at an
odds ratio of 5.46 (95% confidence interval 2.31–13.0)
(P < 0.01). Of the 23 women admitted to intensive care, 20
underwent gynaecological surgery: 3 of the operations were
emergencies and 17 were elective. Reoperation was carried
out in 12 cases, either because of postoperative haemor-
rhage or procedure-related injuries. Women who ended up inthe ICU for reasons unrelated to surgery were one who was
admitted to the hospital because of ovarian hyperstimulation
syndrome and two with uterine bleeding problems.
The reasons for admission to the ICU are given in Table 2.
The most common reasons were postoperative haemorrhage,
disease-related complications and infections, with 43% of the
23 cases in need of intensive care being due to haemor-
rhage, 39% due to infection, 34% due to respiratory failure or
heart failure, 9% due to procedure-related injuries and 8%
due to other reasons. Causes of haemorrhage included surgi-
cal bleeding (n = 7) and use of anticoagulants (n = 3). One
nonsurgical case of haemorrhage was because of profuse
dysfunctional uterine bleeding in adolescence. Infections
included six cases of septic infection, two of which were sec-
ondary to procedure-related injury (one to the bowel and one
to the ureter). Many women had multiple complications and
were included in more than one category. Anaesthesia was
not considered to be the primary cause of or a contributing
factor to severe morbidity in any case.
Table 3 lists interventions in the ICU. We do not have a
formal policy concerning the use of pulmonary artery
catheters and their use is based on the clinical judgement of
the intensivist in charge. However, the clinical practice is to
use a pulmonary artery catheter when a patient is haemody-
namically unstable or has severe respiratory failure. Vasoac-
tive drugs such as norepinephrine, epinephrine, dobutamine
and dopamine are not usually used without a pulmonary
artery catheter. The high rate of utilisation of pulmonary
catheters has not changed in recent years. There were two
patients requiring haemodialysis. The first patient was a 46-
year-old woman who had had insulin-dependent diabetes for
40 years. She had neuropathy, retinopathy and nephropathy.
After operation she developed oliguria and pulmonary
oedema unresponsive to vasodilating drugs and diuretics.
The other patient was a 70-year-old woman who postopera-
tively developed sepsis and oliguria.
The overall outcome for women admitted to the ICU was
favourable among those treated for reasons other than malig-
nancy, but four deaths (17%) occurred in patients with gynae-
cological malignancy after they had been transferred to ward
care. This in-hospital mortality pattern indicates how extremely ill
the group with malignancy was. Two of these patients died as a
result of unresponsive septic shock in the ward, one died of pul-
monary embolism and one of uncontrolled bleeding. In each
case, a multidisciplinary team made the decision not to readmit
cancer patients having a poor prognosis (advanced ovarian
cancer) to the ICU. The problems that arose were not consid-
ered to be a result of poor treatment, but simply beyond the
reach of critical care medicine. The causes of death were sub-
sequently confirmed at autopsy. The APACHE II score did not
predict the death. After hospital discharge, all but one of the sur-
viving patients returned to their previous social and physical
activity. In one case of narcotising fasciitis, clinical improvement
followed surgical debridement of superficial fascia and subcuta-
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Table 1
Clinical characteristics of gynaecological patients (n = 23)
transferred to the intensive care unit
Characteristic Finding
Mean age (years) (± SD) 55.4 (± 16.9)
BMI (kg/m2)(± SD) 25.6 (± 5.6)
Pre-existing medical disorder 9 (39%)
Gynaecological malignancy 8 (35%)
No surgery 3 (13%)
Time in intensive care unit (d) (± SD) 4.97 (± 9.28) range 1–42
APACHE II score (± SD) 14.1 (± 5.57)
ARDS 1 (4.4%)
Deaths 0 (%)
APACHE II, Acute Physiological and Chronic Health Evaluation II;
ARDS, adult respiratory distress syndrome; BMI, body mass index.
Table 2
Reasons for admission of gynaecological patients to the
intensive care unit
Reason n (%)
Postoperative haemorrhage 10 (43%)
Infection 9  (39%)
Cardiovascular disease 7 (30%)
Procedure-related injury 2 (9%)
Pulmonary embolism 1 (4%)
Dysfunctional uterine bleeding in adolescence 1 (4%)
Ovarian hyperstimulation syndrome 1 (4%)
Table 3
Interventions for gynaecological patients in the intensive care
unit
Intervention n (%)
Arterial line 23 (100%)
Central line 5 (22%)
Swan–Ganz catheter 18 (78%)
Blood transfusion 13 (56%)
Mechanical ventilation 15 (65%)
Vasoactive infusion 12 (52%)
Haemodialysis 2 (9%)neous tissue of the abdominal wall. Two more cancer patients
(9%) died within the 6-month follow-up period.
The mean (± SD) cost of one TISS point was $31 (± 2) and
the total cost of intensive care for the (23 surviving) gynaeco-
logical patients was $154,969. This accounted for 0.28% of
all costs incurred by the intensive care offered in our hospital.
Consequently, the mean cost of ICU treatment was $7044
per gynaecological patient.
Discussion
The need for gynaecological critical care was infrequent, and
overall the results of this study give a somewhat pessimistic
picture of clinical outcome, with 26% mortality within
6 months. Most of the women who ended up in intensive care
had undergone surgery and were classified as being at high
risk, reflecting the fact that the risk of serious morbidity is
especially relevant to those judged to be at high risk because
of gynaecological malignancy or pre-existing medical disor-
ders. Mortality for cancer patients admitted to ICUs have
been reported to range from 40% to 80% as regards solid
tumors [9]. A marked association was also observed in our
patients between postoperative haemorrhage and need for
intensive care. Urinary and gastrointestinal tract injuries
during gynaecological procedures appeared to be relatively
common in cancer surgery and they accounted for almost a
tenth of all admissions. The validity of the current results is
high, since the study presents a regional outcome, avoiding
the selection bias inherent in multicentre studies. Another
advantage is that all patients in the referral population requir-
ing intensive care were included in the study. The mean
length of time of intensive care required was of the order of 5
days and the mean cost of treatment of each critically ill
woman in the ICU was of the order of $7044, without includ-
ing ancillary costs incurred by treatment in the hospital ward.
In this study, the frequency of gynaecological critical care
was 2.3 per 1000 women undergoing major surgery.
However, in a clinical setting it is difficult to compare frequen-
cies as such, since indications for admission differ consider-
ably according to the availability of facilities offering advanced
in-patient gynaecological care. Accordingly, whatever the
level of care, a severe postoperative haemorrhage may
threaten the life of a women, without subsequent need for
intensive care. However, we recorded no postoperative mor-
tality with ward care alone, and therefore the level of care
appears to have been appropriate. On the other hand, this
kind of study cannot fully answer the question of what would
have happened without the possibility of intensive care.
Massive postoperative haemorrhage is still a major cause of
severe morbidity in gynaecological care, but within the sub-
group of critically ill patients, gynaecological malignancy is a
major cause of in-hospital death. A delay in the correction of
hypovolaemia, in the diagnosis and treatment of defective
coagulation or in the surgical control of bleeding are the
avoidable factors in most postoperative near-miss cases
caused by haemorrhage. A multidisciplinary team involving a
gynaecologist, anaesthetist and haematologist best manages
these rare complications. Early diagnosis and treatment of
patients at high risk may also curtail potentially grave conse-
quences of severe infections. Primary repair of urinary and
gastrointestinal tract injuries is most likely to be successful if
done at the time of injury. Patients with pre-existing medical
conditions, such as cardiovascular and respiratory disorders,
might benefit from improved preoperative evaluation of pul-
monary function and a pulmonary rehabilitation programme to
reduce the risk of respiratory failure. On the other hand,
anaesthesia-related severe morbidity was not seen.
The results of this study indicate that the reasons for and fre-
quency of critical care have not changed greatly over the past
few years. On the other hand, we acknowledge that admis-
sion and discharge criteria may change over 7 years, even
when the same physicians are making decisions. Similarly,
the decision to not admit a severely ill patient who is beyond
surgical treatment or who has progressive terminal disease
may change. Furthermore, the decision to proceed to surgery
in patients with, for example, cardiovascular disease, a deci-
sion outside the purview of the intensivists, may well change
over time, thereby influencing the frequency of admissions.
Finally, the current study does not include severely ill patients
seen elsewhere who qualified for admission for intensive care
at Kuopio University Hospital but died before they reached
the unit.
Conclusions
Our data show that the need for intensive care in gynaecol-
ogy often occurs in cancer patients. Although the need for
intensive care is often unforeseeable and unavoidable, post-
operative haemorrhage and pre-existing medical disorders
are often related to subsequent severe morbidity. Thus, in
certain patients presenting with conditions placing them in a
high-risk category, clinical suspicion, advanced preparation
and timing of operation may decrease the severity of a devel-
oping event. When a gynaecological patient needs intensive
care, the length of stay is usually short. Capuzzo et al. [10]
reported that after discharge from hospital, most general
patients who had been admitted to the ICU returned to their
preadmission physical activity and social status, and this
finding also applies to the surviving gynaecological patients in
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Key messages
• Few gynaecological patients develop complications
requiring intensive care.
• Malignancy and comorbidities increase the risk.
• The length of stay is usually short.
• The mortality is not predicted by the APACHE II score.the present study. However, the presence of malignancy may
contribute to death in a way not predictable by the APACHE
II score, but this scoring system has not been validated for
gynaecological patients and the accuracy of the score in
gynaecological patients needs further clarification. Overall,
the information obtained in this study may be useful not only
for counselling purposes but also when allocating resources.
Of course, the need for intensive care should not be the only
outcome measure considered in the quality of gynaecological
care, but it must be one of the most important ones.
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